GenXys Company Research Report

Company Overview

• Name: GenXys

• Mission: To redefine the prescribing process with a focus on precision medicine, using AI-enhanced insights to empower all stakeholders for optimal outcomes.

• Founded by: No information is available

• Key People:

• Bernard Esquivel MD, PhD, MAS - Chief Executive Officer

• Martin Dawes MB.BS MD FRCGP - Founder and Scientific Director

• Mark Gelfer MD FCFP(C) - Chairman of the Board

• Marco Barcella MS MBA - Advisory Board Member

• Paul Owen BBA - Advisory Board Member

• Chet Robson DO MBA FAAFP - Advisory Board Member

• Headquarters: No information is available

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: GenXys is renowned for revolutionizing the prescription process using AI-driven solutions to streamline medication selection, safety reviews, and authorization processes.

Products

GenXys offers various products focused on precision medicine and personalized prescribing solutions:

1. LabGx

• Description: Genotype-phenotype integration tool.

• Key Features: Unlocks genomic insights by integrating lab results into clinical decision-making for precision prescribing.

2. CDSS (Clinical Decision Support System)

• Description: Precision Prescribing CDSS.

• Key Features: Personalizes treatment plans with real-time, evidence-based recommendations tailored to each patient’s unique profile.

3. IdentifyGx

• Description: Population Health Rx Stratification.

• Key Features: Identifies high-risk patients and optimizes care pathways using advanced data analytics and predictive modeling.

4. OptimizeGx

• Description: Prescription Authorization Optimization Tool.

• Key Features: Streamlines the prior authorization process for specialty medications, reducing delays and improving patient access to essential therapies.

Recent Developments

• New Products Launched: No specific information is available regarding new products.

• New Features Added to Existing Products: No specific information is available regarding new features.

• New Partnerships: GenXys has been recognized as a valuable partner by healthcare providers and diagnostics companies, notably collaborating with organizations like Bridge Diagnostics to enhance pharmacogenomics services.

Additional Information

GenXys commits to patient-centric precision medicine solutions, offering seamless integration with existing electronic health records (EHR) and laboratory information systems (LIS), customization capabilities, and a scalable, cost-effective SaaS model to eliminate large upfront costs. Their approach emphasizes evidence-based decision-making, streamlining complex processes, and facilitating personalized prescribing for improved health outcomes.